{
  "docId": "019dd923-5ca1-7489-b638-229be117d58e",
  "docSlug": "415e33cb189c4261",
  "documentTitle": "Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors",
  "authorId": "LEK",
  "authorName": "L.E.K.",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 9,
  "pageCount": 13,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "data_table",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 18,
  "notes": "The chart displays multi-select survey data.",
  "elementsJson": [
    "headline_text",
    "bar_chart_horizontal",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b638-229be117d58e/9",
  "deckHref": "/decks/019dd923-5ca1-7489-b638-229be117d58e",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b638-229be117d58e.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-229be117d58e#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.92,
        "x": 0.04,
        "y": 0.32
      },
      "kind": "chart",
      "text": "Grouped horizontal bar chart showing survey responses for Overall, US, and Asia (ex-China) categories.",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "519141f9-c646-4d05-829b-b3b7e6f068f4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.03,
        "y": 0.89
      },
      "kind": "disclaimer",
      "text": "*Survey question: Has your company already made any strategic adjustments in response to the US BIOSECURE Act? Select those which apply (Multi-select)\nSource: L.E.K. 2024 Global Survey on Impact of US BIOSECURE Act",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c405dc0a-2085-4981-abd4-d3088ce672c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Percentage of respondents: 68%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd951-c7ca-701b-9cc5-99e28ecd80d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.94,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Sixty-eight percent of global life sciences companies have made strategic adjustments, including increasing legal and compliance requirements, diversifying partnerships and adding background checks",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b503fa56-9bcc-49ec-a15f-dae7ecb08b70",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.04,
        "y": 0.22
      },
      "kind": "title",
      "text": "Strategic adjustments made in response to the US BIOSECURE Act*",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3a5b9239-37ad-439e-91cd-ba9a8978184b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [
    {
      "metricRaw": "Percentage of respondents",
      "numberRaw": "68%",
      "numberKind": "percent",
      "actionTitle": "Sixty-eight percent of global life sciences companies have made strategic adjustments, including increasing legal and compliance requirements, diversifying partnerships and adding background checks",
      "calloutText": null,
      "numberScale": null,
      "numberValue": 68,
      "metricFamily": "survey_sentiment",
      "numberCurrency": null
    }
  ],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 6,
      "beatId": "f22e8876-c901-4ea3-b100-be2f21d5e929",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The document presents data and findings from L.E.K.'s survey",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "04a5278d-7e5b-4b55-a8c7-0de1c16bfa6b",
      "evidence": "The document presents data on the potential impact of the Act on partnerships with Chinese companies",
      "position": 0,
      "objective": "Highlighting the consequences of not adapting to the US BIOSECURE Act",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}